LIMERICK, Ireland, April 3,
2023 /CNW/ - kneat.com, inc. (TSX: KSI) (OTC:
KSIOF) ("Kneat" or "the Company"), a leader
in digitizing and automating validation and quality processes, is
pleased to announce it has signed a three-year Master Services
Agreement ("the Agreement") with a division of one of the 20
largest pharmaceutical companies in the world, as ranked by 2021
revenue. The Agreement is effective immediately and allows the
company to scale Kneat across all its business divisions and
affiliates.
Implementation of the Agreement, which is for elogbook
management within the company's quality control laboratories, is
expected to commence and go live in Q2 2023. The division, which
specializes in therapies for rare diseases and operates from dozens
of locations worldwide, was introduced to Kneat by a global
consulting partner.
Eddie Ryan, Chief Executive
Officer of Kneat, commented, "Today's win is not just a beachhead
in another of the world's largest pharmas; it also demonstrates the
appeal of Kneat's applicability for use cases outside of validation
and the importance of our partners. Whether it's elogbooks in a
lab, or the commissioning and qualification of new equipment on a
factory floor, Kneat is a key digital transformation partner for
life science. Managing quality processes digitally from end to end,
with no paper anywhere, delivers ROI and peace of mind for the
teams responsible for the health and safety of patients."
About Kneat
Kneat, a Canadian company with operational headquarters in
Limerick, Ireland, develops and
markets the next generation Kneat Gx SaaS platform. Multiple
business work processes can be configured on the platform from
equipment to computer validation, through to quality document
management. Kneat's software allows users to author, review,
approve, execute testing online, manage any exceptions, and
post-approve final deliverables in a controlled FDA 21 CFR Part 11/
EU Annex 11-compliant platform. Macro and micro report dashboards
enable powerful oversight into all systems, projects and processes
globally. Customer case studies are reporting productivity
improvements in excess of 100% and a higher data integrity and
compliance standard. For more information
visit www.kneat.com
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein,
certain information presented constitutes "forward-looking
information" within the meaning of applicable Canadian securities
laws. Such forward-looking information includes, but is not limited
to, the relationship between Kneat and the customer, Kneat's
business development activities, the use and implementation
timelines of Kneat's software within the customer's validation
processes, the ability and intent of the customer to scale the use
of Kneat's software within the customer's organization and the
compliance of Kneat's platform under regulatory audit and
inspection. While such forward-looking statements are expressed by
Kneat, as stated in this release, in good faith and believed by
Kneat to have a reasonable basis, they are subject to important
risks and uncertainties. As a result of these risks and
uncertainties, the events predicted in these forward-looking
statements may differ materially from actual results or events.
These forward-looking statements are not guarantees of future
performance, given that they involve risks and uncertainties.
Kneat does not undertake any obligation to release publicly
revisions to any forward-looking statement, except as may be
required under applicable securities laws. Investors should not
assume that any lack of update to a previously issued
forward-looking statement constitutes a reaffirmation of that
statement. Continued reliance on forward-looking statements is at
an investor's own risk.
SOURCE kneat.com, inc.